OX40/OX40L in Systemic Lupus Erythematosus
Author Information
Author(s): Farres Mohamed N., Al-Zifzaf Dina S., Aly Alaa A., Abd Raboh Nermine M.
Primary Institution: Ain Shams University, Cairo, Egypt
Hypothesis
The study evaluates the role of OX40/OX40L as markers of disease activity and nephritis in SLE patients.
Conclusion
OX40-OX40L interaction plays a role in the pathogenesis of SLE, and the expression of OX40 on CD4+ T-lymphocytes may serve as a marker of lupus nephritis.
Supporting Evidence
- OX40 expression was significantly higher in SLE patients than in controls.
- Serum OX40L levels were significantly higher in SLE patients with nephritis than in those without.
- OX40 expression correlated positively with serum creatinine levels and disease activity.
Takeaway
This study found that a specific protein called OX40 on immune cells can help doctors understand how active lupus is and if a patient has kidney problems.
Methodology
A case-control study assessing OX40 expression and serum OX40L levels in SLE patients and healthy controls.
Potential Biases
Potential selection bias due to the specific patient population from a single institution.
Limitations
The study was limited to a specific population and may not be generalizable to all SLE patients.
Participant Demographics
40 SLE patients (20 with nephritis, 20 without) and 20 healthy controls, primarily female.
Statistical Information
P-Value
<0.01
Confidence Interval
0.81 to 0.99
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website